PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001122D0053Omnibus IV military medical research and — Vysnova Partners, Inc

Vysnova Partners, Inc holds $50.5M across 65 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards in the incumbent pipeline. Set-aside status: NONE.

Defense Health Agency

Awarding office

Vysnova Partners, Inc

Recipient

—

Estimated value

AN14

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Vysnova Partners, Inc — $90

Contract facts

NONE

Contract numberHT001122D0053

Also listed asHT0011-22-D-0053

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentVysnova Partners, Inc

UEIWG9BBL96G436

PSCAN14

Related solicitationHT001121R0004

OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES is a federal NONE award for Defense Health Agency held by Vysnova Partners, Inc. Estimated value —. Related solicitation HT001121R0004.

OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES

Incumbent footprint

Public record

Vysnova Partners, Inc — $50.5M obligated across 65 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($50.5M) · all agencies

Department of Defense (DOD)$46.0M · 91%Department of Health and Human Services (HHS)$4.2M · 8%Department of Transportation (DOT)$326K · 1%

Open full company profile →

Related awards

Same incumbent

HT942524F0319

CLINICAL RESEARCH SUPPORT SERVICES

$1.5M

Sep 27, 2026

N0018926FA001

RESEARCH AND ADMINISTRATION SUPPORT SERVICES IN SUPPORT OF NAVAL MEDICAL RESEARCH UNIT SOU…

$4.6M

Mar 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001122D0053?

HT001122D0053 (Omnibus IV military medical research and) is a Defense Health Agency award with an estimated value of —, currently held by Vysnova Partners, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0011-22-D-0053?

HT0011-22-D-0053 is the dashed form of PIID HT001122D0053 (Omnibus IV military medical research and), held by Vysnova Partners, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001122D0053?

Defense Health Agency awarded HT001122D0053 to Vysnova Partners, Inc.

Who is the incumbent on HT001122D0053?

Vysnova Partners, Inc is the incumbent with $50.5M across 65 related awards in SCOUT’s public footprint.

When does Vysnova Partners, Inc’s HT001122D0053 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HT001122D0053 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 23, 2026 · refreshed monthly